ATE484274T1 - Zusammensetzung zur wiederherstellung des vaginalen ökosystems - Google Patents

Zusammensetzung zur wiederherstellung des vaginalen ökosystems

Info

Publication number
ATE484274T1
ATE484274T1 AT04012486T AT04012486T ATE484274T1 AT E484274 T1 ATE484274 T1 AT E484274T1 AT 04012486 T AT04012486 T AT 04012486T AT 04012486 T AT04012486 T AT 04012486T AT E484274 T1 ATE484274 T1 AT E484274T1
Authority
AT
Austria
Prior art keywords
composition
restoring
vaginal ecosystem
ecosystem
vaginal
Prior art date
Application number
AT04012486T
Other languages
English (en)
Inventor
Paolo Senin
Ivo Setnikar
Elena Tacconi
Angelo Luigi Rovati
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE484274T1 publication Critical patent/ATE484274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04012486T 2003-05-30 2004-05-26 Zusammensetzung zur wiederherstellung des vaginalen ökosystems ATE484274T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000404A ITTO20030404A1 (it) 2003-05-30 2003-05-30 Composizione per il ripristino dell'ecosistema vaginale

Publications (1)

Publication Number Publication Date
ATE484274T1 true ATE484274T1 (de) 2010-10-15

Family

ID=33105065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04012486T ATE484274T1 (de) 2003-05-30 2004-05-26 Zusammensetzung zur wiederherstellung des vaginalen ökosystems

Country Status (4)

Country Link
EP (1) EP1481666B1 (de)
AT (1) ATE484274T1 (de)
DE (1) DE602004029528D1 (de)
IT (1) ITTO20030404A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20061912A1 (it) * 2006-10-04 2008-04-05 S I I T Srl Composizioni farmaceutiche topiche vaginali
WO2009155118A1 (en) * 2008-05-30 2009-12-23 Reprotect, Inc. Compositions and methods for inactivation of pathogens at genital tract surfaces
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
WO2012158779A1 (en) 2011-05-17 2012-11-22 Reprotect, Inc. Reusable intravaginal delivery device, system, and method
WO2017058175A1 (en) 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
IT201700086482A1 (it) * 2017-07-27 2019-01-27 Farma Derma S R L Composizione per il trattamento della vaginosi batterica
BR112023015558A2 (pt) 2021-04-16 2023-11-14 Unilever Ip Holdings B V Composição de limpeza aquosa sem sulfato para higiene íntima feminina, uso não terapêutico de uma composição aquosa e método não terapêutico para fornecer higiene intima feminina
CN115137873B (zh) * 2022-07-26 2023-02-03 广西博生生物科技有限公司 一种用于阴道微生态调节的妇科流体敷料制剂的制备

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system

Also Published As

Publication number Publication date
EP1481666A1 (de) 2004-12-01
ITTO20030404A1 (it) 2004-11-30
EP1481666B1 (de) 2010-10-13
DE602004029528D1 (de) 2010-11-25

Similar Documents

Publication Publication Date Title
DE60129823D1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
ATE238783T1 (de) Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten
HK1120522A1 (en) Cell growth inhibitors containing anti-glypican 3 antibody
DE69528039D1 (de) Inhibitoren der fettsäuresynthese als antimikrobielle mittel
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
MY138759A (en) Treatment of huntington's disease with epa
NO20033664D0 (no) Mikroorganisme for biologisk detoksifisering av mykotoksiner, dvs okratoksiner og/eller zearleoner, så vel som fremgangsmåte og anvendelsederav
TW200700725A (en) Detection of nucleic acid associated with disease
ATE484274T1 (de) Zusammensetzung zur wiederherstellung des vaginalen ökosystems
ATE435657T1 (de) Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung
ATE298246T1 (de) Aktiviertes protein c zur behandlung von pankreatitis
MXPA02000504A (es) Metodo de purificar agua, bacterias adecuadas para el metodo y uso de las mismas.
AU2002316917A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
ATE362974T1 (de) Kultivierungsverfahren für mikroorganismen und bioreaktor
ATE547117T1 (de) Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung
ATE303075T1 (de) Teilhydrolysierte fischgelatine enthaltende zubereitungen und deren verwendung
ATE374593T1 (de) Methode zur haarbehandlung gekennzeichnet durch applikation bestimmter 2-hydroxyalkansäuren
ATE474567T1 (de) Kombinationspräparate enthaltend 2- methylthiazolidin-2,4-dicarbonsäure
PT1380208E (pt) Agente desinfectante com actividade antiparasitica
DE60213441D1 (de) Verwendung des aminoglycosidresistenzgens
UA33352U (ru) СПОСОБ ОПРЕДЕЛЕНИЯ АНТИЛИЗОЦИМНОЙ АКТИВНОСТИ БАКТЕРИЙ E. coli
FR2863497B1 (fr) Nouvelles compositions pharmaceutiques et/ou dietetiques contre le stress
AU2001228257A1 (en) Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan
UA37144U (ru) Способ определения антилизоцимной активности сальмонелл
DE60305592D1 (de) Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties